Salarius Pharmaceuticals, Inc.

Contributing Author

Recent Articles by Salarius Pharmaceuticals, Inc.

Sep-09	Salarius Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Requirement SLRX GlobeNewswire
Aug-14	Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split SLRX GlobeNewswire
Jul-14	Salarius Pharmaceuticals Granted Additional Extension to Regain Compliance with Nasdaq's Stockholders' Equity Standard SLRX GlobeNewswire
Jul-09	Salarius Pharmaceuticals' Seclidemstat Demonstrates Supporting Role in Inhibiting Validated Oncology Target LSD1 in Two Recently Published Studies SLRX GlobeNewswire